No CrossRef data available.
Article contents
The role of the ASPL-TFE3 fusion protein in Alveolar Soft Part Sarcoma
Published online by Cambridge University Press: 30 July 2021
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- 3D Structures: From Macromolecular Assemblies to Whole Cells (3DEM FIG)
- Information
- Copyright
- Copyright © The Author(s), 2021. Published by Cambridge University Press on behalf of the Microscopy Society of America
References
Cooney, I., etc. (2019) Structure of the Cdc48 segregase in the act of unfolding an authentic substrate, Science 365, 502-505.CrossRefGoogle ScholarPubMed
Xia, D., etc. (2016) Structure and function of the AAA+ ATPase p97/Cdc48p, Gene 583, 64-77.CrossRefGoogle ScholarPubMed
Meyer, H., etc. (2014) The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis, Journal of cell science 127, 3877-3883.Google Scholar
Haines, D. S. (2010) p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association?, Genes & cancer 1, 753-763.CrossRefGoogle ScholarPubMed
Orme, C. M., etc. (2012) The ubiquitin regulatory X (UBX) domain-containing protein TUG regulates the p97 ATPase and resides at the endoplasmic reticulum-golgi intermediate compartment, The Journal of biological chemistry 287, 6679-6692.Google ScholarPubMed
Arumughan, A., etc. (2016) Quantitative interaction mapping reveals an extended UBX domain in ASPL that disrupts functional p97 hexamers, Nature communications 7, 13047.CrossRefGoogle ScholarPubMed
Ladanyi, M., etc. (2001) The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25, Oncogene 20, 48-57.CrossRefGoogle ScholarPubMed
Joyama, S., etc. (1999) Chromosome rearrangement at 17q25 and xp11.2 in alveolar soft-part sarcoma: A case report and review of the literature, Cancer 86, 1246-1250.Google ScholarPubMed
Vistica, D. T., etc. (2008) Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of alveolar soft part sarcoma, Journal of pediatric hematology/oncology 30, 46-52.Google ScholarPubMed
Brady, O. A., etc. (2018) The transcription factors TFE3 and TFEB amplify p53 dependent transcriptional programs in response to DNA damage, eLife 7.Google ScholarPubMed
Tsuda, M., etc. (2007) TFE3 fusions activate MET signaling by transcriptional up- regulation, defining another class of tumors as candidates for therapeutic MET inhibition, Cancer research 67, 919-929.CrossRefGoogle ScholarPubMed
You have
Access